Published in Am J Clin Nutr on January 11, 2012
Pilot study of vitamin D supplementation in adults with cystic fibrosis pulmonary exacerbation: A randomized, controlled trial. Dermatoendocrinol (2012) 1.17
Meta-analysis of long-term vitamin D supplementation on overall mortality. PLoS One (2013) 1.03
Low Dietary Intake of Vitamin D and Vitamin D Deficiency in Hemodialysis Patients. J Nephrol Ther (2014) 0.88
Effect of oral vitamin D analogs on mortality and cardiovascular outcomes among adults with chronic kidney disease: a meta-analysis. Clin Kidney J (2014) 0.84
Vitamin D supplementation in pre-dialysis chronic kidney disease: A systematic review. Dermatoendocrinol (2012) 0.84
Ergocalciferol Supplementation in Hemodialysis Patients With Vitamin D Deficiency: A Randomized Clinical Trial. J Am Soc Nephrol (2015) 0.81
Which vitamin D in CKD-MBD? The time of burning questions. Biomed Res Int (2013) 0.79
Efficacy and safety of body weight-adapted oral cholecalciferol substitution in dialysis patients with vitamin D deficiency. BMC Nephrol (2015) 0.77
Very high-dose cholecalciferol and arteriovenous fistula maturation in ESRD: a randomized, double-blind, placebo-controlled pilot study. J Vasc Access (2013) 0.77
Effect of cholecalciferol supplementation on inflammation and cellular alloimmunity in hemodialysis patients: data from a randomized controlled pilot trial. PLoS One (2014) 0.77
Long-term cholecalciferol administration in hemodialysis patients: a single-center randomized pilot study. Med Sci Monit (2014) 0.75
Vitamin D prohormone in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease. Int J Nephrol Renovasc Dis (2017) 0.75
Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2011) 23.10
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis (2003) 16.18
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl (2009) 12.66
Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int (2006) 7.02
Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int (2007) 6.35
Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr (2004) 6.02
Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab (2004) 3.71
Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr (1998) 2.72
Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study. Nephrol Dial Transplant (2010) 2.64
Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler Thromb Vasc Biol (2008) 2.32
Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. Annu Rev Pharmacol Toxicol (2011) 1.97
Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort study. Am J Clin Nutr (2008) 1.95
Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients. Nephron Clin Pract (2007) 1.65
Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol (2010) 1.63
Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters. Clin J Am Soc Nephrol (2010) 1.60
Fortification of orange juice with vitamin D: a novel approach for enhancing vitamin D nutritional health. Am J Clin Nutr (2003) 1.36
Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers. Nephrol Dial Transplant (2008) 1.34
Short-term effects of high-dose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, double-blind, placebo-controlled pilot study. Crit Care (2011) 1.33
Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study. Endocr Pract (2008) 1.29
Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients. J Ren Nutr (2008) 1.22
Cord blood vitamin D status impacts innate immune responses. J Clin Endocrinol Metab (2011) 1.14
Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation. Nephrol Dial Transplant (2009) 1.14
Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment. Nephron Clin Pract (2008) 1.13
High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients. Nephrol Dial Transplant (2008) 1.12
Vitamin D(3) down-regulates proinflammatory cytokine response to Mycobacterium tuberculosis through pattern recognition receptors while inducing protective cathelicidin production. Cytokine (2011) 1.05
Vitamin D3 distribution and status in the body. J Am Coll Nutr (2009) 0.99
Cross-sectional analysis of abnormalities of mineral homeostasis, vitamin D and parathyroid hormone in a cohort of pre-dialysis patients. The chronic renal impairment in Birmingham (CRIB) study. Nephron Clin Pract (2007) 0.98
A controlled study of vitamin D3 to prevent bone loss in renal-transplant patients receiving low doses of steroids. Transplantation (2005) 0.95
Impact of hypovitaminosis D and alfacalcidol therapy on survival of hemodialysis patients: results from the French ARNOS study. Nephron Clin Pract (2010) 0.92
Inhibition of proliferation and induction of apoptosis by 25-hydroxyvitamin D3-3beta-(2)-Bromoacetate, a nontoxic and vitamin D receptor-alkylating analog of 25-hydroxyvitamin D3 in prostate cancer cells. Clin Cancer Res (2004) 0.91
Effects of long-term cholecalciferol supplementation on mineral metabolism and calciotropic hormones in chronic kidney disease. Kidney Blood Press Res (2008) 0.87
Effect of depot oral cholecalciferol treatment on secondary hyperparathyroidism in stage 3 and stage 4 chronic kidney diseases patients. Ren Fail (2008) 0.87
Adynamic bone disease: clinical and therapeutic implications. Curr Opin Nephrol Hypertens (2009) 0.81
High-dose cholecalciferol supplementation for vitamin D deficiency in haemodialysis patients. J Int Med Res (2011) 0.81
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int (2002) 9.29
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation (2003) 8.61
Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol (2007) 5.91
Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. Lancet (2013) 4.58
Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med (2003) 4.58
Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2009) 4.04
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation (2003) 3.94
Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int (2005) 3.71
Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology (2003) 3.70
Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum (2005) 3.17
Increased concentration of proatherogenic inflammatory cytokines in systemic lupus erythematosus: relationship to cardiovascular risk factors. J Rheumatol (2006) 3.10
A human protein complex homologous to the Drosophila MSL complex is responsible for the majority of histone H4 acetylation at lysine 16. Mol Cell Biol (2005) 3.04
Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med (2004) 2.97
Absence of coronary artery calcification and all-cause mortality. JACC Cardiovasc Imaging (2009) 2.86
Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J Transl Med (2009) 2.49
Progression of coronary artery calcium predicts all-cause mortality. JACC Cardiovasc Imaging (2010) 2.48
Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation (2002) 2.47
Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler Thromb Vasc Biol (2008) 2.32
Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med (Berl) (2010) 2.25
Sex differences in mental stress-induced myocardial ischemia in young survivors of an acute myocardial infarction. Psychosom Med (2014) 2.12
Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med (2003) 2.10
Coronary aging in HIV-infected patients. Clin Infect Dis (2009) 2.02
High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors. Ann Rheum Dis (2006) 2.00
Diagnostic performance of fusion of myocardial perfusion imaging (MPI) and computed tomography coronary angiography. J Nucl Cardiol (2009) 1.99
Ethnic differences in the prognostic value of coronary artery calcification for all-cause mortality. J Am Coll Cardiol (2007) 1.99
TGF-alpha expression as a potential biomarker of risk within the normal-appearing colorectal mucosa of patients with and without incident sporadic adenoma. Cancer Epidemiol Biomarkers Prev (2009) 1.98
Prognostic value of coronary artery calcium screening in asymptomatic smokers and non-smokers. Eur Heart J (2006) 1.96
High prevalence of hypovitaminosis D status in patients with early Parkinson disease. Arch Neurol (2011) 1.95
Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials. Endocr Pract (2009) 1.93
Optimal vitamin D status attenuates the age-associated increase in systolic blood pressure in white Americans: results from the third National Health and Nutrition Examination Survey. Am J Clin Nutr (2008) 1.86
Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease. Arch Neurol (2008) 1.86
The proneural molecular signature is enriched in oligodendrogliomas and predicts improved survival among diffuse gliomas. PLoS One (2010) 1.86
Trends in ATP-III-defined high blood cholesterol prevalence, awareness, treatment and control among U.S. adults. Ann Epidemiol (2007) 1.84
Vascular calcification in chronic kidney disease. Am J Kidney Dis (2004) 1.81
Epicardial adipose tissue and coronary artery plaque characteristics. Atherosclerosis (2009) 1.77
Heritability and seasonal variability of vitamin D concentrations in male twins. Am J Clin Nutr (2010) 1.73
Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis (2007) 1.73
Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. J Am Coll Cardiol (2011) 1.72
Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients. Am Heart J (2005) 1.72
Structure of apolipoprotein A-I in spherical high density lipoproteins of different sizes. Proc Natl Acad Sci U S A (2008) 1.71
A comparison of methods for estimating the causal effect of a treatment in randomized clinical trials subject to noncompliance. Biometrics (2008) 1.70
Coronary artery calcium screening: current status and recommendations from the European Society of Cardiac Radiology and North American Society for Cardiovascular Imaging. Int J Cardiovasc Imaging (2008) 1.67
Progression of coronary artery calcium in men affected by human immunodeficiency virus infection. Int J Cardiovasc Imaging (2011) 1.63
Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms. Arthritis Rheum (2008) 1.63
Vitamin D deficiency and risk for cardiovascular disease. Am J Med Sci (2009) 1.62
Determinants of progressive vascular calcification in haemodialysis patients. Nephrol Dial Transplant (2004) 1.61
Novel solid-state-detector dedicated cardiac camera for fast myocardial perfusion imaging: multicenter comparison with standard dual detector cameras. J Nucl Cardiol (2009) 1.60
Effects of vitamin D and calcium supplementation on markers of apoptosis in normal colon mucosa: a randomized, double-blind, placebo-controlled clinical trial. Cancer Prev Res (Phila) (2009) 1.59
Prognostic value of number and site of calcified coronary lesions compared with the total score. JACC Cardiovasc Imaging (2008) 1.57
Validity of the primary care diagnosis of diabetes in veterans in the southeastern United States. Diabetes Res Clin Pract (2010) 1.57
Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum (2009) 1.56
Calcium and vitamin D: skeletal and extraskeletal health. Curr Rheumatol Rep (2008) 1.54
Effect of intensive versus moderate lipid-lowering therapy on epicardial adipose tissue in hyperlipidemic post-menopausal women: a substudy of the BELLES trial (Beyond Endorsed Lipid Lowering with EBT Scanning). J Am Coll Cardiol (2013) 1.54
Epicardial adipose tissue is an independent marker of cardiovascular risk in HIV-infected patients. AIDS (2011) 1.53
Continuous probabilistic prediction of angiographically significant coronary artery disease using electron beam tomography. Circulation (2002) 1.52
Phosphorus levels are associated with subclinical atherosclerosis in the general population. Atherosclerosis (2008) 1.48
Development of a cardiovascular calcification index using simple imaging tools in haemodialysis patients. Nephrol Dial Transplant (2006) 1.46
Development of a bedside tool to predict time to death after withdrawal of life-sustaining therapies in infants and children. Pediatr Crit Care Med (2012) 1.45
Study design and subject baseline characteristics in the ADVANCE Study: effects of cinacalcet on vascular calcification in haemodialysis patients. Nephrol Dial Transplant (2010) 1.44
Improvement of pain, sleep, and quality of life in chronic pain patients with vitamin D supplementation. Clin J Pain (2013) 1.43
Hybrid myocardial imaging for risk stratification prior to kidney transplantation: added value of coronary calcium and epicardial adipose tissue. J Nucl Cardiol (2013) 1.41
Accumulation of retained nonfunctional arteriovenous grafts correlates with severity of inflammation in asymptomatic ESRD patients. Nephrol Dial Transplant (2012) 1.41
Serum 25-hydroxyvitamin D concentrations and prevalence estimates of hypovitaminosis D in the U.S. population based on assay-adjusted data. J Nutr (2012) 1.40
Increased expression of miR-421 in human gastric carcinoma and its clinical association. J Gastroenterol (2009) 1.40
Trends in the prevalence, awareness, treatment, and control of cardiovascular disease risk factors among noninstitutionalized patients with a history of myocardial infarction and stroke. Am J Epidemiol (2006) 1.36
Cannot exclude torsion--a 15-year review. J Pediatr Surg (2009) 1.34
A systematic review and meta-analysis of the relationship between lipoprotein lipase Asn291Ser variant and diseases. J Lipid Res (2006) 1.32
Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis. Arthritis Res Ther (2006) 1.31
Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density. Nephrol Dial Transplant (2005) 1.29
Immunohistochemical study on p53, H-rasp21, c-erbB-2 protein and PCNA expression in HCC tissues of Han and minority ethnic patients. World J Gastroenterol (2000) 1.29
Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study. Endocr Pract (2008) 1.29
Vitamin D is linked to carotid intima-media thickness and immune reconstitution in HIV-positive individuals. Antivir Ther (2011) 1.28
High coronary artery calcium scores pose an extremely elevated risk for hard events. J Am Coll Cardiol (2002) 1.27
Effects of supplemental vitamin D and calcium on oxidative DNA damage marker in normal colorectal mucosa: a randomized clinical trial. Cancer Epidemiol Biomarkers Prev (2010) 1.26
25-hydroxyvitamin D status of healthy, low-income, minority children in Atlanta, Georgia. Pediatrics (2010) 1.25
Epicardial adipose tissue volume and coronary artery calcium to predict myocardial ischemia on positron emission tomography-computed tomography studies. J Nucl Cardiol (2010) 1.25
Evaluation of vitamin D repletion regimens to correct vitamin D status in adults. Endocr Pract (2009) 1.24
Comparison of prognostic usefulness of coronary artery calcium in men versus women (results from a meta- and pooled analysis estimating all-cause mortality and coronary heart disease death or myocardial infarction). Am J Cardiol (2007) 1.24
Novel cardiovascular risk factors in premature coronary atherosclerosis associated with systemic lupus erythematosus. J Rheumatol (2008) 1.24
Coronary artery calcium as a measure of biologic age. Atherosclerosis (2005) 1.24
Vitamin D status and antimicrobial peptide cathelicidin (LL-37) concentrations in patients with active pulmonary tuberculosis. Am J Clin Nutr (2010) 1.22
Detection of high-risk young adults and women by coronary calcium and National Cholesterol Education Program Panel III guidelines. J Am Coll Cardiol (2005) 1.22
Thoracic aorta calcification detected by electron beam tomography predicts all-cause mortality. Atherosclerosis (2009) 1.22
Interplay of coronary artery calcification and traditional risk factors for the prediction of all-cause mortality in asymptomatic individuals. Circ Cardiovasc Imaging (2012) 1.22
Postchallenge plasma glucose excursions, carotid intima-media thickness, and risk factors for atherosclerosis in Chinese population with type 2 diabetes. Atherosclerosis (2009) 1.22
Calcification in atherosclerosis. Nat Rev Cardiol (2009) 1.20
Vitamin D and bone health in adults with cystic fibrosis. Clin Endocrinol (Oxf) (2008) 1.20
Three-dimensional graphene foam as a biocompatible and conductive scaffold for neural stem cells. Sci Rep (2013) 1.18
Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients: comparative efficacy of ergocalciferol, cholecalciferol, and UV light. J Clin Endocrinol Metab (2009) 1.17
Pilot study of vitamin D supplementation in adults with cystic fibrosis pulmonary exacerbation: A randomized, controlled trial. Dermatoendocrinol (2012) 1.17
Serum 25-hydroxyvitamin D concentrations are associated with prevalence of metabolic syndrome and various cardiometabolic risk factors in US children and adolescents based on assay-adjusted serum 25-hydroxyvitamin D data from NHANES 2001-2006. Am J Clin Nutr (2011) 1.17
Validity of depression rating scales during pregnancy and the postpartum period: impact of trimester and parity. J Psychiatr Res (2010) 1.17
Stochastic modeling and prediction for accrual in clinical trials. Stat Med (2010) 1.16